Related by context. Frequent words. (Click for all words.) 73 proteasome inhibitor 73 Factor VIIa 72 targeting CD# 71 liposomal formulation 71 SERMs 71 Carfilzomib 70 squalamine 70 Mipomersen 70 Panzem R 70 immunomodulating 70 SARMs 70 Tesetaxel 70 proteasome inhibitors 70 enzyme inhibitors 69 ATL# [001] 69 enzyme inhibitor 69 orally bioavailable 69 Aliskiren 69 ALN TTR# 69 polymerase inhibitors 69 murine model 69 Denufosol 69 vascular disrupting agent 69 Azedra 69 anticancer compound 69 BZL# 69 multi kinase inhibitor 69 tyrosine kinase inhibitor 69 secondary hyperparathyroidism 69 photodynamic therapy PDT 68 nitric oxide donating 68 Microplasmin 68 CCX# 68 PEGylated 68 PSN# [002] 68 Cetrorelix 68 MEK inhibitor 68 anti fibrotic 68 antiangiogenic 68 humanized antibody 68 Recombinant Human 68 immune modulator 68 Dapagliflozin 68 refractory chronic lymphocytic 68 antibody fragment 68 immunomodulator 68 myeloproliferative disorders 68 angiogenesis inhibitor 67 Dasatinib 67 Guanilib 67 iSONEP 67 EVIZON 67 Proxinium TM 67 immunomodulatory 67 arterial thrombosis 67 CA4P 67 novel anticancer 67 predictive biomarkers 67 adenoviral 67 neovascular age 67 Bortezomib 67 Elesclomol 67 Vandetanib 67 DDP# 67 Trastuzumab 67 Daclizumab 67 Drug Candidate 67 therapeutic monoclonal antibodies 67 molecularly targeted 67 Adenosine 67 #ME# 67 molecular biomarkers 67 TLR9 agonist 66 Epratuzumab 66 pertuzumab 66 prodrugs 66 immunological diseases 66 INCB# [001] 66 photodynamic 66 PEG SN# 66 Milnacipran 66 humanized anti 66 IMC #B 66 bleomycin 66 polymerase inhibitor 66 ThermoDox R 66 Traficet EN 66 antiproliferative 66 Taxol ® 66 Zolinza 66 neuroprotective properties 66 Targretin 66 EndoTAG TM -1 66 P#X# 66 Diabetic Macular Edema 66 Clofarabine 66 Natalizumab 66 Phase III Clinical Trial 66 R sorafenib tablets 66 eprotirome 66 Onalta